# Paul Brenchley

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-brenchley/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,957 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 51 |
| i10-index | 137 |
| Last Known Institution | Manchester Academic Health Science Centre |
| OpenAlex ID | https://openalex.org/A5031802922 |
| ORCID iD | 0000-0003-1290-9919 |
| Works | 253 |

## Researcher papers

- [Genetically Distinct Subsets within ANCA-Associated Vasculitis](https://scholariq.org/papers/genetically-distinct-subsets-within-anca-associated-vasculitis/)
- [IDENTIFICATION OF POLYMORPHISMS WITHIN THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENE: CORRELATION WITH VARIATION IN VEGF PROTEIN PRODUCTION](https://scholariq.org/papers/identification-of-polymorphisms-within-the-vascular-endothelial-growth-factor/)
- [Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy](https://scholariq.org/papers/rituximab-or-cyclosporine-in-the-treatment-of-membranous-nephropathy/)
- [Risk HLA-DQA1 and PLA <sub>2</sub> R1 Alleles in Idiopathic Membranous Nephropathy](https://scholariq.org/papers/risk-hla-dqa1-and-pla-sub-2-sub-r1-alleles-in-idiopathic-membranous-nephropathy/)
- [Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter.](https://scholariq.org/papers/haplotype-analysis-of-the-polymorphic-human-vascular-endothelial-growth-factor/)
- [Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy](https://scholariq.org/papers/anti-pla2r-antibodies-measured-by-elisa-predict-long-term-outcome-in-a-prevalent/)
- [Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy](https://scholariq.org/papers/antiphospholipase-a2-receptor-antibody-titer-and-subclass-in-idiopathic/)
- [Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients](https://scholariq.org/papers/mesangial-iga1-in-iga-nephropathy-exhibits-aberrant-o-glycosylation-observations/)
- [Vascular Endothelial Growth Factor (VEGF) is Released from Platelets during Blood Clotting: Implications for Measurement of Circulating VEGF Levels in Clinical Disease](https://scholariq.org/papers/vascular-endothelial-growth-factor-vegf-is-released-from-platelets-during-blood/)
- [A road map for efficient and reliable human genome epidemiology](https://scholariq.org/papers/a-road-map-for-efficient-and-reliable-human-genome-epidemiology/)
- [Membranous nephropathy: thinking through the therapeutic options](https://scholariq.org/papers/membranous-nephropathy-thinking-through-the-therapeutic-options/)
- [Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New‐incident and relapsing primary membranous nephropathy](https://scholariq.org/papers/intravenous-pulse-cyclophosphamide-and-steroids-induce-immunological-and/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

## Researcher university

- [Manchester Academic Health Science Centre](https://scholariq.org/institutions/manchester-academic-health-science-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.